Awakn Life Sciences Corp.: Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO

Seasoned Leader Brings Deep Knowledge of US Biotech Market to Awakn
Toronto, Ontario--(Newsfile Corp. - June 7, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology

Related Keywords

United Kingdom ,New York ,United States ,Columbia University ,Canada ,Toronto ,Ontario ,America ,Anne Donohoe ,Embera Pharma ,Paul Jarman Nora Popova ,Dennis Purcell ,Anthony Tennyson ,Linkedin Facebook ,Awakn Life Sciences ,Endowment Committee ,Fund Senior Managing Partner ,Ichnos Pharmaceuticals ,Better Health ,York State Bio Defense Initiative ,Awakn Life Sciences Corp ,University Of Delaware ,Newsfile Corp ,Strategic Communications ,Life Sciences Investment Banking Group At Chase ,Alliance For Regenerative Medicine Foundation ,Life Sciences ,Founder Of Aisling Capital ,Seasoned Leader Brings Deep Knowledge ,Alcohol Use Disorder ,Special Advisor ,Aisling Capital ,New York City ,Senior Managing Partner ,Executive Committee ,Managing Director ,Life Sciences Investment Banking Group ,Real Endpoints ,Summus Global ,Shorla Oncology ,Pharmaceutical Innovation ,New York Bio ,Investor Advisory Board ,Biotechnology Innovation Organization ,Health Care Board ,New York State Bio Defense Initiative ,Regenerative Medicine ,Alcohol Use ,United States Securities Act ,Awakn ,Life ,Ciences ,Orp ,Ppoints ,Biotech ,Investment ,Veteran ,Tennis ,Purcell ,Special ,Advisor ,